Clinical Trials, Consumption, Seminar and Treatment

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Trials

Consumption

Seminar

Treatment

The John Hopkins Center for Psychedelic and Consciousness Research Publishes Inaugural Edition Of Newsletter

Cannabis Law Report

NOVEMBER 24, 2019

Future studies will explore psilocybin’s effectiveness as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol use in people with major depression. December 3, 2019. December 4, 2019.

Therapy

Therapy Treatment Medicine Clinical Trials

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). upcoming seminars). 14) and general information or guidelines for practitioners ( n ?=?6).

Research and Development

Research and Development Medicine Access Media

Medical Cannabis Brief

The John Hopkins Center for Psychedelic and Consciousness Research Publishes Inaugural Edition Of Newsletter

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Stay Connected